Pepticom Ltd., an innovative leader in the realm of Artificial Intelligence for peptide discovery, has successfully raised an impressive $6,600,000 in its latest funding round. This exciting milestone comes as a testament to the company’s groundbreaking technology, developed from research at the esteemed Hebrew University. Pepticom’s intelligent platform revolutionizes the conventional methods of peptide discovery, enabling the identification of both innovative peptides and other molecules with remarkable efficiency. The capabilities of this disruptive technology not only accelerate the research process but also significantly reduce costs, making high-quality discoveries accessible to a broader range of applications in pharmaceuticals, agriculture, and animal well-being.
The newly acquired funding will be instrumental in propelling Pepticom’s ongoing projects, which include strategic collaborations with industry giants like ADAMA in agriculture and several major players in the pharmaceutical field. These partnerships are set to advance the development of new drug candidates and enhance agricultural efficiencies, addressing critical challenges across healthcare and food production. With the financial backing now in place, Pepticom is poised to expand its AI-driven discovery capabilities, further cementing its position as a frontrunner in peptide innovation. As the world increasingly seeks efficient and effective solutions to its pressing health and agricultural needs, Pepticom stands at the forefront of this transformation, driven by a vision to harness the power of AI to revolutionize the discovery process.
.png&w=3840&q=75)
